Back to 
Saba Capital Management, L.P.
Saba Capital Management, L.P.
BSX
Showing 0 of 5 quarters
Position history for Saba Capital Management, L.P.'s holdings in Boston Scientific Corporation
No. Saba Capital Management exited its BSX (Boston Scientific) position in Q2 2023. Its Q1 2023 13F listed 4,730 shares worth $236,642. Saba Capital Management first reported BSX in Q2 2022 and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.